Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41 results about "Chromoprotein" patented technology

A chromoprotein is a conjugated protein that contains a pigmented prosthetic group (or cofactor). A common example is haemoglobin, which contains a heme cofactor, which is the iron-containing molecule that makes oxygenated blood appear red. Other examples of chromoproteins include other hemochromes, cytochromes, phytochromes and flavoproteins.

Inclusion compound for improving photostability of chromoprotein and application of inclusion compound

The invention particularly discloses an inclusion compound for improving the photostability of chromoprotein and application of the inclusion compound. The inclusion compound is prepared from an inclusion formed by at least one polyphenol molecule or partial groups of the polyphenol molecule in a cyclodextrin cavity; a polyphenol-cyclodextrin inclusion can improve the photostability of the chromoprotein, thereby helping the chromoprotein keep natural luster and activity; a protecting effect of the polyphenol-cyclodextrin inclusion is remarkably superior to a direction effect of polyphenol, and adverse influence of direct contact between the polyphenol and the chromoprotein can be reduced; the polyphenol-cyclodextrin inclusion can be mixed with the chromoprotein; sugar or sugar alcohol also can be added as an accessory in a mixing process and then a mixture is applied to a formula of food or cosmetics. According to the inclusion compound disclosed by the invention, pretreatment of the chromoprotein is avoided, and the structure of the chromoprotein is not changed, so that photodegradation of the chromoprotein is remarkably reduced, accurate luster of the chromoprotein also can be maintained, and important realistic significance for application of the chromoprotein in the cosmetics and the food is realized.
Owner:西安科艺诗生物技术有限公司

Method for separating and preparing medical phycocyanin from alga

The invention belongs to the field of protein engineering, in particular to a method for separating and preparing medical phycocyanin from alga. The method comprises the steps of processing alga plants by an ultrasonic assistant extraction technology at low temperature, extracting alga protein by a protein extraction buffer solution to obtain a coarse extract; then adjusting pH of the coarse extract to be acidic, standing, centrifuging clear liquid and taking supernatant and adjusting pH to be neutral; or adjusting pH of the coarse extract to be acidic, performing membrane filtration after standing to obtain a filtrate; and subjecting the filtrate to hydroxyapatite column chromatography, wherein the moving phase is the protein extraction buffer solution, collecting eluting peak of phycocyanin, and then carrying out spray-drying to obtain the medical phycocyanin. The method for separating and preparing the medical phycocyanin from the alga provided by the invention overcomes the deficiency that the yield is low and the cost is high in the prior art for extracting the phycocyanin. The alga chromoprotein composite with the phycocyanin purity of A620/A280 of more than 2.0 and the recover rate of the phycocyanin of more than 25% is obtained for the first time, and therefore, the method for separating and preparing the medical phycocyanin from the alga provided by the invention simplifies the separating steps, and is simple to operate and reduces the cost. The property of the phycocyanin is stable.
Owner:FUZHOU UNIV

Method for separating and purifying sulodexide crude drugs from heparin by-product

The invention discloses a method for separating and purifying sulodexide crude drugs from a heparin by-product, and relates to the technical field of medicine. The method for separating and purifyingthe sulodexide crude drugs from the heparin by-product comprises the steps that a heparin sulfate and dermatan sulfate crude product is obtained after the heparin by-product is dissolved by adopting high-temperature precipitation separation; and then, a crude product solution is oxidized, precipitated and dried through a hydrogen peroxide-ozone system to obtain sulodexide. According to the methodfor separating and purifying the sulodexide crude drugs from the heparin by-product, the hydrogen peroxide-ozone system is adopted during oxidation, and the oxidation effect can be improved to effectively remove chromoprotein and impurities. During precipitation, compared with a traditional low-temperature precipitation method, a high-temperature precipitation method is adopted, the titer recoveryrate is increased by 10%, using of a centrifugal machine and ion exchange resin is further reduced, compared with traditional hydrogen peroxide oxidation treatment, 60% time is shortened, the productquality and production efficiency are improved, the method for separating and purifying the sulodexide crude drugs from the heparin by-product is suitable for large-scale industrial production, the period is short, the cost is low, the heparin by-product is sufficiently and effectively used, the product purity is higher, and the stability is higher.
Owner:HUBEI YINUORUI BIOLOGICAL PHARMA

Reagent for coloration of protein in gel electrophoresis as well as using method and application

The invention discloses a reagent for coloration of protein in gel electrophoresis as well as a using method and application. The reagent comprises a first component and a second component, wherein the first component is the solution formed by dissolving the compound with isothiocyanic acid groups into a solvent for protecting the isothiocyanic acid groups; the second component is the alkaline loading buffer which does not contain amino groups; the using method comprises the steps as follows: mixing the first component and the second component to form treating fluid and mixing the treating fluid with a to-be-tested protein sample, or mixing the second component with the to-be-tested protein sample and then adding the first component, and heating to form the chromoprotein sample solution. According to the invention, the reagent can be used in gel electrophoresis, and has the advantages of simplicity and easiness in use, reliability in effect, low usage amount, easiness in production and processing, wide application range, no pollution, time conservation and labor conversation, capabilities of performing real-time observation and being used for pre-colorating of the protein in gel electrophoresis, and the like, and a protein electrophoresis pattern has no changes which can be observed.
Owner:安徽昊拓生物科技有限公司

A preparation process for intravenous injection of human immunoglobulin

ActiveCN109575129BImprove securityNot likely to affect biological activityPeptide preparation methodsImmunoglobulinsOctanoic AcidsBlood plasma
The invention relates to the field of medicine, in particular to a preparation process for intravenous injection of human immunoglobulin. The present invention uses octanoic acid instead of ethanol as a precipitant to precipitate acidic proteins in plasma, while IgG molecules with a higher isoelectric point remain in the supernatant, and can be transferred to the chromatography process with only one step of precipitation reaction; octanoic acid is used Salt can inactivate lipid-enveloped viruses and even some non-lipid-enveloped viruses in a relatively short period of time under relatively mild conditions. The action time is short and the effect is good. It is not easy to affect the biological activity of immunoglobulins and improve product safety. High stability, ensuring the quality and yield of the product; using a two-step chromatography process to remove most polymers and other impurity proteins, reduce pyrogens, and also adsorb colored proteins such as ceruloplasmin, effectively improving the appearance of the product Adopt one-step precipitation reaction, reduce loss and increase product yield, which is a preparation process for intravenous injection of human immunoglobulin with high product yield and purity and good safety.
Owner:GUIZHOU TAIBANG BIOLOGICAL PROD

Whole-cell biosensor for detecting p-nitrophenol and detection method

The invention discloses a whole-cell biosensor for detecting p-nitrophenol and a detection method, the whole-cell biosensor for detecting p-nitrophenol comprises a host cell and a pPNP-mrfp plasmid or a pPNP-ami1CP plasmid located in the host cell, the nucleotide sequence of the pPNP-mrfp plasmid is shown as SEQ ID NO: 1, the nucleotide sequence of the pPNP-ami1CP plasmid is shown as SEQ ID NO: 2, and the nucleotide sequence of the pPNP-mrfp plasmid or the nucleotide sequence of the pPNP-ami1CP plasmid is shown as SEQ ID NO: 3. The nucleotide sequence of the pPNP-amilCP plasmid is as shown in SEQ ID NO: 2, and the physical map of the pPNP-mrfp plasmid and the physical map of the pPNP-amilCP plasmid are as shown in figure 1. When the whole-cell biosensor is used for detecting extracted paranitrophenol in soil, the combination of paranitrophenol and repressor protein pobR eliminates the combination of pobR and manipulating gene locus (pobO), reverse fluorescent protein or chromoprotein genes are transcribed to generate fluorescent protein or chromoprotein, and by detecting the fluorescence intensity value or absorbance value, the content of paranitrophenol in the soil can be detected. The rapid and high-throughput detection of the extracted p-nitrophenol in the soil is realized.
Owner:SHENZHEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products